Medication-related impulse control and repetitive behaviors in Parkinson disease
- PMID: 17698698
- DOI: 10.1001/archneur.64.8.1089
Medication-related impulse control and repetitive behaviors in Parkinson disease
Abstract
A range of behaviors presumed to be related to aberrant or excessive dopaminergic medications are being increasingly recognized in Parkinson disease. These behaviors are linked by their incentive- or reward-based and repetitive natures and include pathological gambling, hypersexuality, compulsive shopping, compulsive eating, hobbyism, and compulsive medication use. Such behaviors can have potentially devastating psychosocial consequences and are often hidden. Whether these behaviors are simply related to dopaminergic medications interacting with an underlying individual vulnerability or whether the primary pathological features of Parkinson disease play a role is not known. We reviewed the literature on these behaviors in Parkinson disease, including definitions, epidemiological and potential pathophysiological features, and management. The study of these behaviors allows not only improved clinical management but also greater insight into a biologically mediated complex behavioral model.
Similar articles
-
Medication-related impulse control and repetitive behaviors in Parkinson's disease.Curr Opin Neurol. 2007 Aug;20(4):484-92. doi: 10.1097/WCO.0b013e32826fbc8f. Curr Opin Neurol. 2007. PMID: 17620886 Review.
-
[Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].Geriatr Psychol Neuropsychiatr Vieil. 2011 Jun;9(2):227-35. doi: 10.1684/pnv.2011.0275. Geriatr Psychol Neuropsychiatr Vieil. 2011. PMID: 21690031 Review. French.
-
Impulsive and compulsive behaviors in Parkinson's disease.Mov Disord. 2009 Aug 15;24(11):1561-70. doi: 10.1002/mds.22505. Mov Disord. 2009. PMID: 19526584 Review.
-
Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.Neurol Sci. 2004 Jun;25(2):98-101. doi: 10.1007/s10072-004-0238-z. Neurol Sci. 2004. PMID: 15221629
-
Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.Physiol Behav. 2011 Jul 25;104(1):168-72. doi: 10.1016/j.physbeh.2011.04.055. Epub 2011 May 5. Physiol Behav. 2011. PMID: 21557955 Review.
Cited by
-
The addiction-related gene ANKK1 in Parkinsonian patients with impulse control disorder.Neurotox Res. 2015 Apr;27(3):205-8. doi: 10.1007/s12640-014-9504-x. Epub 2014 Dec 2. Neurotox Res. 2015. PMID: 25447970
-
Treatment of Apathy in Parkinson's Disease and Implications for Underlying Pathophysiology.J Clin Med. 2024 Apr 11;13(8):2216. doi: 10.3390/jcm13082216. J Clin Med. 2024. PMID: 38673489 Free PMC article. Review.
-
Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability.Parkinsonism Relat Disord. 2011 Mar;17(3):153-5. doi: 10.1016/j.parkreldis.2010.11.015. Epub 2010 Dec 24. Parkinsonism Relat Disord. 2011. PMID: 21186135 Free PMC article.
-
Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers.Neurology. 2013 Feb 26;80(9):792-9. doi: 10.1212/WNL.0b013e3182840678. Epub 2013 Jan 16. Neurology. 2013. PMID: 23325911 Free PMC article. Clinical Trial.
-
Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.CNS Drugs. 2010 Nov;24(11):941-68. doi: 10.2165/11537810-000000000-00000. CNS Drugs. 2010. PMID: 20932066 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical